In summary, reducing the level of PTPN2 in cells can markedly reduce the malignancy of PAAD, suggesting that PTPN2 plays critical roles in regulating PAAD and is a potential target to develop novel anti-cancer drugs. Here, PTPN2 is linked to pancreatic adenocarcinoma.